BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes
News | 01. 05. 2016
Afferent Pharmaceuticals
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes.
